MG
EW icon

MilWealth Group’s Edwards Lifesciences EW Stock Holding History

MilWealth Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24
Closed -$3.11K – 108
2021
Q4 		$3.11K Hold
24
– – ﹤0.01% 109
2021
Q3 		$2.72K Buy
+24
New +$2.74K ﹤0.01% 117

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MilWealth Group's EW Position: Q1 2022 in Review

MilWealth Group sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 24 shares — an estimated $3.11K sold.

MilWealth Group first reported a position in EW in Q3 2021 and held it in 2 quarters. The position peaked at $3.11K in Q4 2021. 1,314 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • MilWealth Group reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • MilWealth Group sold 24 Edwards Lifesciences shares in Q1 2022, an estimated $3.11K.
  • MilWealth Group first reported a position in Edwards Lifesciences in Q3 2021 and held it in 2 quarters.
  • MilWealth Group's Edwards Lifesciences position peaked at $3.11K in Q4 2021.
  • 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on MilWealth Group's 13F filing for Q1 2022, filed 9 May 2023.